Skip to main navigation Skip to search Skip to main content

In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD)

  • M Haghighi
  • , L Jahangard
  • , H Mohammad-Beigi
  • , H Bajoghli
  • , H Hafezian
  • , Serge Brand

Research output: Contribution to journalArticlepeer-review

Original languageUndefined/Unknown
Pages (from-to)633-640
Number of pages8
JournalPsychopharmacology
Volume228
Issue number4
Publication statusPublished - 2013

Cite this